Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictio: Drug Efficacy in Chronic Low Back Pain
NCT01179828Phase 3Completed
- Sponsor
- Insel Gruppe
- Start
- Jul 2010
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone, clobazam, imipramine in chronic low back pain (CLBP), sponsored by Insel Gruppe. Started Jul 2010; status: completed.
02
Drugs
oxycodoneclobazamimipramine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT01179828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01179828.